title: [A case of brucellosis presenting with urinary tract infection].
abstract: In this report an acute brucellosis case presenting with the symptoms of urinary tract infection (UTI) has been discussed. A 29 years old male patient was admitted to the emergency service of our hospital with the complaints of acute UTI. His complaints were persisting for five days before admission. His physical examination was normal but there were fever (39 degrees C) and costovertebral angle tenderness. His medical history revealed that multiple stones in the lower pole of the right kidney and paranchyme loss were detected by IVP two years ago. The bacteria that were isolated from blood and urine cultures were identified as Brucella melitensis by conventional methods. Rose Bengal test was found positive, and standard tube agglutination test was positive at a titer of 1/640. The patient was treated with oral ciprofloxacin (1000 mg/day) and rifampicin (600 mg/day) combination for six weeks. The aim of this presentation was to draw attention to this uncommon condition, as UTI symptoms are not the first symptoms of acute brucellosis. UTI symptoms should be carefully considered as a presentation of brucellosis especially in regions where brucellosis is endemic.
authors.affiliation: Başkent Universitesi Tip Fakültesi, Adana Uygulama ve Araştirma Merkezi, Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali, Adana.
authors.forename: Hikmet
authors.initials: H
authors.lastname: Uncu
authors.forename: Yusuf Z
authors.initials: YZ
authors.lastname: Demiroğlu
authors.forename: Umit
authors.initials: U
authors.lastname: Gül
authors.forename: Sezgin
authors.initials: S
authors.lastname: Güvel
authors.forename: Tuba
authors.initials: T
authors.lastname: Turunç
authors.forename: Sule
authors.initials: S
authors.lastname: Cokaloğlu
authors.forename: Hande
authors.initials: H
authors.lastname: Arslan
mesh_terms: D000208:Acute Disease; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D017347:Brucella melitensis / Q000145:classification / Q000302:isolation & purification*; D002006:Brucellosis / Q000175:diagnosis* / Q000188:drug therapy; D002939:Ciprofloxacin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D012293:Rifampin